Since early in 2008, the Prostate Cancer Roundtable has acted as a forum through which all members of the U.S. prostate cancer advocacy community can act in concert to ensure a shared set of policy and scientific priorities that affect the prevention, detection of risk, diagnosis, and management of prostate cancer–the most commonly diagnosed form of cancer in men. Our fundamental objective is to ensure that we all work together on priorities that will lead to:

  • A major decrease in the annual incidence of newly diagnosed cases of prostate cancer
  • The early diagnosis and optimal treatment of all cases of clinically significant prostate cancer
  • Access to high quality care for all men diagnosed with this disease

Support Our
Policy Agenda

The Prostate Cancer Roundtable encourages local and regional prostate cancer-specific organizations and patient groups to support our agenda …
Learn more

Click here to print a copy of the Policy Agenda to distribute to your members and supporters, and to share with policy makers and elected officials.

Who Belongs
to the Roundtable?

The membership of the Prostate Cancer Roundtable includes major, independent U.S.-based prostate cancer advocacy organizations …
Learn more

What’s on
the “Hot Seat”?

The Roundtable responds to new AUA screening guidelines; expresses concern about the confusion caused by contradictory guidelines. Read here.

Read the April 2013 letter to Sec. Sebelius about the next director of AHRQ here.

Read our response to the USPSTF PCa screening recommendation here. Read more here.